Browse By: Country ι Category ι Tag
Home  »  Ovarian Cancer

Ovarian Cancer Market Research Reports

More

Global Ovarian Cancer Drugs Market Report 201
Roche Boehringer Ingelheim Amgen AstraZeneca GlaxoSmithKline ABRAXANE Doxil Exelixis DelMar Pharmaceuticals Inc Bristol-Myers Squibb Celgene Alkeran Lynparza Novartis Pharmaceuticals Corp Clovis Oncology Alza Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Ovarian Cancer Drugs in these regions, from 2011 to 2021 (forecast), like North America China Europe Japan Latin America India Row Split by Product Types, with production, revenue, price, market share and growth rate of each type, can be divided into Oral Therapy Injectable Therapy Others Split by applications, this report focuses on consumption, market share and growth rate of Ovarian Cancer Drugs in each application, can be divided int
Published Date: Feb 2017
Published By: QYResearch

Price: $2955
Ovarian Cancer - Pipeline Review, H2 2016
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape. Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, changes in bowel habits, such as constipation, loss of appetite and low back pain. The predisposing factors include age and family history. Treatment includes surgery, chemotherapy and radiation therapy. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Ovarian C
Published Date: Dec 2016
Published By: Global Markets Direct

Price: $2500
Avastin (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Avastin (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Avastin sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Gemzar (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Gemzar (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Gemzar sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2004-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Farletuzumab (Ovarian Cancer) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Farletuzumab (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Farletuzumab sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Note: This is
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Votrient (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Votrient (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Votrient sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope The
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Opaxio (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Opaxio (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Opaxio sales forecasts for the US. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profi
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Doxil/Caelyx (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Doxil/Caelyx sales estimates for the US, EU and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Vargatef (Ovarian Cancer) Analysis and Forecats to 2020
GlobalDatas pharmaceuticals report, Vargatef (Ovarian Cancer) - Analysis and Forecats to 2020 provides Vargatef sales forecasts for the US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2017-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Note: This is a on-demand report
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Karenitecin (Ovarian Cancer) Analysis and Forecast to 2020
GlobalDatas pharmaceuticals report, "Karenitecin (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Karenitecin sales estimates for the US, EU and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Paclical (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, "Paclical (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Paclical sales estimates for the US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Thera
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Paclitaxel (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, "Paclitaxel (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Paclitaxel sales forecasts for the US, EU and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Cisplatin (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, "Cisplatin (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Cisplatin sales forecasts for the US, EU and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
AMG 386 (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, "AMG 386 (Ovarian Cancer) - Analysis and Forecasts to 2020 provides AMG 386 sales forecasts for the US, EU and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope The
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Carboplatin (Ovarian Cancer) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, "Carboplatin (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Carboplatin sales forecasts for the US, EU and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Note: This
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Yondelis (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Yondelis (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Yondelis sales forecasts for EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2009-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area prof
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Recentin (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Recentin (Ovarian Cancer) Analysis and Forecasts to 2020 provides Recentin sales estimates for US, and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy are
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Olaparib (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Olaparib (Ovarian Cancer) Analysis and Forecasts to 2020 provides Olaparib sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2016-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Thera
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
EC145 (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, EC145 (Ovarian Cancer) - Analysis and Forecasts to 2020 provides EC145 sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2016-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy a
Published Date: Oct 2011
Published By: GlobalData

Price: $2000

Back To Top